Experts are rapidly investigating retatrutide, a novel treatment developed by Eli Lilly, as a possible breakthrough in physique loss . Distinct from many earlier approaches, retatrutide is a dual -action receptor targeting equally GLP-1 and GIP, substances that affect hunger and blood sugar cont… Read More